Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Bedia JS"'
Autor:
Bedia JS; Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA., Huang YW; Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA., Gonzalez AD; Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA., Gonzalez VD; Baxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA., Funingana IG; Department of Oncology, University of Cambridge, Cambridgeshire, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, Cambridgeshire, CB2 0RE, UK.; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals, NHS Foundation Trust, Cambridge, UK., Rahil Z; Baxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA., Mike A; Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA., Lowber A; Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA., Vias M; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, Cambridgeshire, CB2 0RE, UK., Ashworth A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 1450 Third Street, San Francisco, CA 94158, USA., Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, Cambridgeshire, CB2 0RE, UK.; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals, NHS Foundation Trust, Cambridge, UK., Fantl WJ; Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA.; Stanford Comprehensive Cancer Institute.; Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Nov 26. Date of Electronic Publication: 2024 Nov 26.
Autor:
Han CY; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Corrigan G; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX., Perez A; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX., Kohring SD; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX., Celestino J; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Bedi D; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, TX., Bedia E; Unity Point Health, John Stoddard Cancer Center, Des Moines, IA., Bevers T; Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, TX., Boruta D; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Carlson M; Department of Obstetrics and Gynecology, University of Texas Southwestern Medical School, Dallas, TX., Holman L; Department of Obstetrics and Gynecology, University of Oklahoma Medical School, Oklahoma City, OK., Leeds L; Women's Hospital, Houston, TX.; Deceased., Mathews C; Women and Infants Hospital, Providence, RI., McCann G; Department of Obstetrics and Gynecology, University of Texas San Antonio School of Medicine, San Antonio, TX., Moore RG; Department of Obstetrics and Gynecology, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY., Schlumbrecht M; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Slomovitz B; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Carol G. Simon Cancer Center, Atlantic Health, Morristown, NJ., Tobias D; Carol G. Simon Cancer Center, Atlantic Health, Morristown, NJ., Williams-Brown Y; Department of Obstetrics and Gynecology, Dell School of Medicine, University of Texas, Austin, TX., Bevers MW; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Liu J; Department of Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Gornet TG; Department of Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Handy BC; Department of Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Lu Z; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX., Bedia JS; MGH Biostatistics, Massachusetts General Hospital, Boston, MA., Skates SJ; MGH Biostatistics, Massachusetts General Hospital, Boston, MA., Bast RC Jr; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 01; Vol. 42 (10), pp. 1102-1109. Date of Electronic Publication: 2024 Jan 09.
Autor:
Young Han C; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bedia JS; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA., Yang WL; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hawley SJ; Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA, USA., Bergan L; Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA, USA., Hopper M; Biodesign Institute, Arizona State University, Tempe, AZ, USA., Celestino J; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Guo J; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gornet TG; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Soosaipillai A; Lurenfeld-Tanebaum Research Institute (LTRI) Sinai Health System, Toronto, ON, Canada., Yang H; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Doskocil SD; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lokshin AE; Departments of Pathology, Medicine, and Obstetrics and Gynecology, University of Pittsburgh Medical Center and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA., Handy BC; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Diamandis EP; Lurenfeld-Tanebaum Research Institute (LTRI) Sinai Health System, Toronto, ON, Canada., Moore RG; Department of Obstetrics and Gynecology, Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lu Z; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Anderson KS; Biodesign Institute, Arizona State University, Tempe, AZ, USA. Karen.Anderson.1@asu.edu., Drescher CW; Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA, USA. cdresche@fredhutch.org., Skates SJ; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA. SSKATES@mgh.harvard.edu., Bast RC Jr; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. rbast@mdanderson.org.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Mar; Vol. 130 (5), pp. 861-868. Date of Electronic Publication: 2024 Jan 09.
Autor:
Funingana IG; Department of Oncology, University of Cambridge, Cambridgeshire, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, Cambridgeshire, UK.; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals, NHS Foundation Trust, Cambridge, UK., Bedia JS; Department of Urology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Huang YW; Department of Urology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Delgado Gonzalez A; Department of Urology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Donoso K; Department of Urology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Gonzalez VD; Baxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Brenton JD; Department of Oncology, University of Cambridge, Cambridgeshire, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, Cambridgeshire, UK.; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals, NHS Foundation Trust, Cambridge, UK., Ashworth A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 1450 Third Street, San Francisco, CA, 94158, USA., Fantl WJ; Department of Urology, Stanford University School of Medicine, Stanford, CA, 94305, USA. wjfantl@stanford.edu.; Stanford Comprehensive Cancer Institute, Stanford, CA, 94305, USA. wjfantl@stanford.edu.; Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, 94305, USA. wjfantl@stanford.edu.
Publikováno v:
Seminars in immunopathology [Semin Immunopathol] 2023 Jan; Vol. 45 (1), pp. 43-59. Date of Electronic Publication: 2023 Jan 12.
Autor:
Lee MY; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Computer Science, Stanford, CA, 94305, USA., Bedia JS; Department of Urology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Bhate SS; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Bioengineering, Stanford University School of Medicine, Stanford, CA, 94305, USA., Barlow GL; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Phillips D; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Fantl WJ; Department of Urology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Nolan GP; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA., Schürch CM; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA. christian.schuerch@med.uni-tuebingen.de.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA. christian.schuerch@med.uni-tuebingen.de.; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany. christian.schuerch@med.uni-tuebingen.de.
Publikováno v:
BMC bioinformatics [BMC Bioinformatics] 2022 Jan 18; Vol. 23 (1), pp. 46. Date of Electronic Publication: 2022 Jan 18.